Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 956-962 , August 2009

Clinical Significance of Serum Hepcidin Levels on Early Infectious Complications in Allogeneic Hematopoietic Stem Cell Transplantation

  • Junya Kanda

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Junya Kanda, MD, Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.
    • ,
  • Chisaki Mizumoto

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Hiroshi Kawabata

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Tatsuo Ichinohe

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Hideyuki Tsuchida

      Affiliations

    • Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan
    • ,
  • Naohisa Tomosugi

      Affiliations

    • Proteomics Research Unit, Division of Advanced Medicine, Medical Research Institute, Kanazawa Medical University, Ishikawa, Japan
    • ,
  • Keitaro Matsuo

      Affiliations

    • Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
    • Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    • ,
  • Kouhei Yamashita

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Tadakazu Kondo

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Takayuki Ishikawa

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
    • ,
  • Takashi Uchiyama

      Affiliations

    • Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Received 27 February 2009 ,Accepted 13 April 2009.

References 

  1. Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant. 2008;41:997–1003
  2. Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109:4586–4588
  3. Altes A, Remacha AF, Sarda P, et al. Early clinical impact of iron overload in stem cell transplantation. A prospective study. Ann Hematol. 2007;86:443–447
  4. Miceli MH, Dong L, Grazziutti ML, et al. Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients. Bone Marrow Transplant. 2006;37:857–864
  5. Morado M, Ojeda E, Garcia-Bustos J, et al. BMT: serum ferritin as risk factor for veno-occlusive disease of the liver. Prospective cohort study. Hematology. 2000;4:505–512
  6. Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42:799–805
  7. Evens AM, Mehta J, Gordon LI. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant. 2004;34:561–571
  8. Kontoyiannis DP, Chamilos G, Lewis RE, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer. 2007;110:1303–1306
  9. Platzbecker U, Bornhauser M, Germing U, et al. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant. 2008;14:1217–1225
  10. Altes A, Remacha AF, Sureda A, et al. Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:987–989
  11. Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15:195–204
  12. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147–150
  13. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806–7810
  14. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306:2090–2093
  15. Ganz T. Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 2005;18:171–182
  16. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276
  17. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276:7811–7819
  18. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–2463
  19. Murao N, Ishigai M, Yasuno H, Shimonaka Y, Aso Y. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Commun Mass Spectrom. 2007;21:4033–4038
  20. Saito T, Yoshioka S, Iinuma Y, et al. Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit. Eur J Clin Microbiol Infect Dis. 2008;27:209–216
  21. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14
  22. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706
  23. Kanda J, Mizumoto C, Kawabata H, et al. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica. 2008;93:1550–1554
  24. Weizer-Stern O, Adamsky K, Amariglio N, et al. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am J Hematol. 2006;81:479–483
  25. Kemna EH, Tjalsma H, Podust VN, Swinkels DW. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem. 2007;53:620–628
  26. McCord JM. Iron, free radicals, and oxidative injury. Semin Hematol. 1998;35:5–12
  27. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol. 2001;113:836–838
  28. Weinberg ED. Iron availability and infection. Biochim Biophys Acta. 2008;[Epub ahead of print]
  29. Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11:482–487
  30. Lee MH, Means RT. Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med. 1995;98:566–571
  31. Olive A, Junca J. Elevated serum ferritin levels: associated diseases and clinical significance. Am J Med. 1996;101:120;author reply 122
  32. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112:4292–4297
  33. Murphy AT, Witcher DR, Luan P, Wroblewski VJ. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood. 2007;110:1048–1054

 Financial disclosure: See Acknowledgments on page 961.

PII: S1083-8791(09)00210-9

doi: 10.1016/j.bbmt.2009.04.008

Biology of Blood and Marrow Transplantation
Volume 15, Issue 8 , Pages 956-962 , August 2009

Article Tools

* Image Usage & Resolution